These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
3. Magnetic resonance imaging of therapy-induced necrosis using gadolinium-chelated polyglutamic acids. Jackson EF; Esparza-Coss E; Wen X; Ng CS; Daniel SL; Price RE; Rivera B; Charnsangavej C; Gelovani JG; Li C Int J Radiat Oncol Biol Phys; 2007 Jul; 68(3):830-8. PubMed ID: 17379450 [TBL] [Abstract][Full Text] [Related]
4. Magnetic resonance imaging of focal liver lesions. Comparison of the superparamagnetic iron oxide resovist versus gadolinium-DTPA in the same patient. Vogl TJ; Hammerstingl R; Schwarz W; Kümmel S; Müller PK; Balzer T; Lauten MJ; Balzer JO; Mack MG; Schimpfky C; Schrem H; Bechstein WO; Neuhaus P; Felix R Invest Radiol; 1996 Nov; 31(11):696-708. PubMed ID: 8915751 [TBL] [Abstract][Full Text] [Related]
5. Low-Molecular-Weight Iron Chelates May Be an Alternative to Gadolinium-based Contrast Agents for T1-weighted Contrast-enhanced MR Imaging. Boehm-Sturm P; Haeckel A; Hauptmann R; Mueller S; Kuhl CK; Schellenberger EA Radiology; 2018 Feb; 286(2):537-546. PubMed ID: 28880786 [TBL] [Abstract][Full Text] [Related]
6. Intercellular imaging by a polyarginine derived cell penetrating peptide labeled magnetic resonance contrast agent, diethylenetriamine pentaacetic acid gadolinium. Guo YM; Liu M; Yang JL; Guo XJ; Wang SC; Duan XY; Wang P Chin Med J (Engl); 2007 Jan; 120(1):50-5. PubMed ID: 17254488 [TBL] [Abstract][Full Text] [Related]
8. Vascular mapping using albumin-(Gd-DTPA), an intravascular MR contrast agent, and projection MR imaging. Moseley ME; White DL; Wang SC; Wikström MG; Dupon JW; Gobbel G; Roth K; Brasch RC J Comput Assist Tomogr; 1989; 13(2):215-21. PubMed ID: 2925907 [TBL] [Abstract][Full Text] [Related]
9. Magnetic resonance imaging of brain perfusion using the nonionic contrast agents Dy-DTPA-BMA and Gd-DTPA-BMA. Kucharczyk J; Asgari H; Mintorovitch J; Vexler Z; Moseley M; Watson A; Rocklage S Invest Radiol; 1991 Nov; 26 Suppl 1():S250-2; discussion S253-4. PubMed ID: 1808141 [No Abstract] [Full Text] [Related]
10. [MR imaging diagnosis of myocardial infarction and an usefulness of Gd-DTPA]. Watanabe S; Imazeki Y; Ishizuya Y Nihon Rinsho; 1994 Jul; 52 Suppl(Pt 1):476-80. PubMed ID: 12436568 [No Abstract] [Full Text] [Related]
11. Diagnosis of symptomatic disc by magnetic resonance imaging: T2-weighted and gadolinium-DTPA-enhanced T1-weighted magnetic resonance imaging. Yoshida H; Fujiwara A; Tamai K; Kobayashi N; Saiki K; Saotome K J Spinal Disord Tech; 2002 Jun; 15(3):193-8. PubMed ID: 12131418 [TBL] [Abstract][Full Text] [Related]
12. Magnetic resonance imaging contrast agents. Design and physicochemical properties of gadodiamide. Chang CA Invest Radiol; 1993 Mar; 28 Suppl 1():S21-7. PubMed ID: 8486500 [No Abstract] [Full Text] [Related]
13. Gadolinium-DTPA-enhanced magnetic resonance scanning in cerebellopontine angle tumors. Wayman JW; Dutcher PO; Manzione JV; Nelson CN; Kido DK Laryngoscope; 1989 Nov; 99(11):1167-70. PubMed ID: 2811558 [TBL] [Abstract][Full Text] [Related]
14. Acute allergic reaction upon first exposure to gadolinium-DTPA: a case report. Rahman SL; Harbinson MT; Mohiaddin R; Pennell DJ J Cardiovasc Magn Reson; 2005; 7(5):849-51. PubMed ID: 16353448 [TBL] [Abstract][Full Text] [Related]
15. Functional hepatobiliary imaging with gadolinium-EOB-DTPA. A comparison of magnetic resonance imaging and 153gadolinium-EOB-DTPA scintigraphy in rats. Schmitz SA; Mühler A; Wagner S; Wolf KJ Invest Radiol; 1996 Mar; 31(3):154-60. PubMed ID: 8675423 [TBL] [Abstract][Full Text] [Related]
16. Magnetic resonance imaging of osteosarcoma using a bis(alendronate)-based bone-targeted contrast agent. Ge P; Sheng F; Jin Y; Tong L; Du L; Zhang L; Tian N; Li G Biomed Pharmacother; 2016 Dec; 84():423-429. PubMed ID: 27682736 [TBL] [Abstract][Full Text] [Related]
17. Measurement of magnetic susceptibility and MR contrast agent concentration. Weis J; Nilsson S; Ericsson A; Wikström M; Sperber GO; Hemmingsson A Magn Reson Imaging; 1994; 12(6):859-64. PubMed ID: 7968285 [TBL] [Abstract][Full Text] [Related]
18. Assessment of myocardial viability using standard extracellular and necrosis specific MR contrast media. Saeed M; Wendland MF; Bremerich GL; Weinmann HJ; Higgins CB Acad Radiol; 2002 May; 9 Suppl 1():S84-7. PubMed ID: 12019905 [No Abstract] [Full Text] [Related]
19. Contrast enhanced liver MRI in patients with primary sclerosing cholangitis: inverse appearance of focal confluent fibrosis on delayed phase MR images with hepatocyte specific versus extracellular gadolinium based contrast agents. Husarik DB; Gupta RT; Ringe KI; Boll DT; Merkle EM Acad Radiol; 2011 Dec; 18(12):1549-54. PubMed ID: 21958599 [TBL] [Abstract][Full Text] [Related]
20. Potential for misinterpretation of combined T1- and T2-weighted contrast-enhanced MR imaging of cartilage. Burstein D; Williams A; McKenzie C; Woertler K; Rummeny EJ Radiology; 2004 Nov; 233(2):619-20; author reply 621-2. PubMed ID: 15516627 [No Abstract] [Full Text] [Related] [Next] [New Search]